The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases
- 31 December 1992
- journal article
- review article
- Published by Elsevier BV in Trends in Biotechnology
- Vol. 10 (6), 200-207
- https://doi.org/10.1016/0167-7799(92)90214-g
Abstract
Uncontrolled matrix metalloproteinase activity is thought to be a cause of the tissue damage observed in many disease processes. None of the drugs currently in use can prevent tissue destruction, and strategies for the development of synthetic inhibitors have been hampered by a poor understanding of the biochemistry of matrix metalloproteinases. Recent cDNA cloning efforts and characterization of recombinant human matrix metalloproteinases have permitted structure-function analysis of the enzymes and their inhibitors. Progress in this area should help indicate a route to rational strategies for designing lead therapeutic compounds.Keywords
This publication has 43 references indexed in Scilit:
- The origin of matrix metalloproteinases and their familial relationshipsFEBS Letters, 1991
- Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)Biochemical Journal, 1991
- Proteolytic inactivation of human α1 antitrypsin by human stromelysinFEBS Letters, 1991
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990
- Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenaseBiochemistry, 1990
- Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)Biochemistry, 1990
- Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetateBiochemistry, 1990
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- Inactivation of human plasma α1‐proteinase inhibitor by human PMN leucocyte collagenaseFEBS Letters, 1990